Financial News

Recent Quotes

My Watchlist

Indicators

Overview

Novavax’s Covid-19 vaccine nearly 90% effective in U.K. study, much less in South Africa

By: Washington Business Journal via Business Journals

January 28, 2021 at 17:14 PM EST

The results make its candidate “the first vaccine to demonstrate not only high clinical efficacy against Covid-19 but also significant clinical efficacy against both the rapidly emerging U.K. and South Africa variants,” Novavax President and CEO Stanley Erck in a statement.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Novavax’s Covid-19 vaccine nearly 90% effective in U.K. study, much less in South Africa

Popular Pages